|
|
EQSNews: Adrenomed AG
/ Key words: Miscellaneous
AdrenoMed Receives FDA Fast Track Designation for Enibarcimab for Treatment of Septic Shock
10.04.2024 / 14:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
Press Release
AdrenoMed Receives FDA Fast Track... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: Adrenomed AG
/ Key words: Study results
Adrenomed presents new findings on its precision medicine treatment for septic shock with enibarcimab during Weimar Sepsis Update
08.09.2023 / 10:00 CET/CEST
The issuer is solely responsible for the content of this announcement.... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: Adrenomed AG
/ Key words: Personnel
Adrenomed appoints Dr. Stephan Witte as Chief Medical Officer
01.02.2023 / 10:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
Press Release
Adrenomed appoints Dr. Stephan Witte as Chief Medical Officer... Lire le communiqué |
|
| |
|
| |
|
|
DGAPNews: Adrenomed AG
/ Key words: Personnel
Adrenomed appoints David Germonpré as Chief Financial Officer
12.07.2022 / 09:30
The issuer is solely responsible for the content of this announcement.
Adrenomed appoints David Germonpré as Chief Financial Officer
Hennigsdorf/Berlin Ger... Lire le communiqué |
|
| |
|
| |
|
|
DGAPNews: Adrenomed AG
/ Key words: Personnel
Adrenomed appoints Dr. med. Steffen Stürzebecher as Chief Medical Officer
23.06.2022 / 09:00
The issuer is solely responsible for the content of this announcement.
Press Release
Adrenomed appoints Dr. med. Steffen Stürzebecher as Chief Medical... Lire le communiqué |
|
| |
|
| |
|
|
DGAPNews: Adrenomed AG
/ Key words: Financing/Study
PEI Regulatory Approval Received for Government Funded Clinical Trial Investigating Adrenomeds Adrecizumab in Treating Endothelial Barrier Dysfunction in Hospitalized COVID19 Patients
11.04.2022 / 09:00
The issuer is solely responsible for the content of this announcement.... Lire le communiqué |
|
| |
|
| |
|
|
DGAPNews: Adrenomed AG
/ Key words: Personnel
Adrenomed Supervisory Board appoints Dr. Richard Jones as CEO
15.03.2022 / 11:00
The issuer is solely responsible for the content of this announcement.
Press Release
Adrenomed Supervisory Board appoints Dr. Richard Jones as CEO
Hennigsdo... Lire le communiqué |
|
| |
|
| |
